DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study

HAEMATOLOGICA 105 巻 9 号 2308-2315 頁 2020-09 発行
アクセス数 : 1349
ダウンロード数 : 0

今月のアクセス数 : 55
今月のダウンロード数 : 0
タイトル
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study
著者
Miyazaki Kana
Asano Naoko
Yamada Tomomi
Miyawaki Kohta
Sakai Rika
Igarashi Tadahiko
Nishikori Momoko
Ohata Kinya
Sunami Kazutaka
Yoshida Isao
Yamamoto Go
Takahashi Naoki
Okamoto Masataka
Yano Hiroki
Nishimura Yuki
Tamaru Satoshi
Nishikawa Masakatsu
Izutsu Koji
Kinoshita Tomohiro
Ohshima Koichi
Kato Koji
Katayama Naoyuki
Yamaguchi Motoko
収録物名
HAEMATOLOGICA
105
9
開始ページ 2308
終了ページ 2315
収録物識別子
ISSN 0390-6078
言語
英語
資源タイプ 学術雑誌論文
出版者
FERRATA STORTI FOUNDATION
発行日 2020-09
アクセス権 メタデータのみ
関連情報
[DOI] 10.3324/haematol.2019.231076
[PMID] 31649127
備考 This study was supported by grants-in-aid from the Japan Agency for Medical Research and Development, AMED (the Practical Research for Innovative Cancer Control; JP15Ack0106157, JP16ck0106157, JP17ck0106157, JP18ck0106439), the Ministry of Labour, Health, and Welfare of Japan (201438142A), the director of Mie University Hospital (2012, 2013), and the National Cancer Center Research and Development Fund (26-A-4, 29-A-3).